Konno R, Sato S, Yajima A
Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan.
Diagn Cytopathol. 1993;9(1):20-4. doi: 10.1002/dc.2840090105.
HPV infection was examined with Cytobrush in exfoliated cervical cells sampled from 347 women. HPV DNA analysis was conducted in two steps. The presence of HPV DNA was demonstrated by dot blotting and typing of HPV DNA was made by Southern blotting using biotinylated probes. Of 167 cases with cervical intra-epithelial neoplasia (CIN) and cervical carcinoma, HPV DNA was detected and typed in 25 cases (15.0%). HPV 16, 18, and 33 were found mainly, and no HPV 6 or 11 was detected. The frequency of HPV DNA was 7.1% of CIN I, 28.6% of CIN II, 54.5% of CIN III, and 50.0% of invasive carcinoma. HPV occurred in patients newly diagnosed as CIN at 25.8% and in those of diagnosed as CIN in the past and followed up, 7.6%. Of 180 healthy women, the screening test of FO8830 was positive for HPV DNA in four women (2.2%). The present system proved to be useful for facilitating large-scale clinical research.
采用细胞刷对347名女性脱落的宫颈细胞进行人乳头瘤病毒(HPV)感染检测。HPV DNA分析分两步进行。通过斑点印迹法证明HPV DNA的存在,并使用生物素化探针通过Southern印迹法对HPV DNA进行分型。在167例宫颈上皮内瘤变(CIN)和宫颈癌病例中,25例(15.0%)检测到HPV DNA并进行了分型。主要发现HPV 16、18和33型,未检测到HPV 6或11型。HPV DNA在CIN I中的检出率为7.1%,在CIN II中为28.6%,在CIN III中为54.5%,在浸润癌中为50.0%。新诊断为CIN的患者中HPV感染率为25.8%,既往诊断为CIN并接受随访的患者中为7.6%。在180名健康女性中,4名女性(2.2%)的FO8830筛查试验HPV DNA呈阳性。目前的系统被证明有助于大规模临床研究。